Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China
- PMID: 35949873
- PMCID: PMC9326378
- DOI: 10.46497/ArchRheumatol.2022.8870
Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China
Abstract
Objectives: This study aims to estimate predicted factors for maternal and fetal outcomes in Hakka pregnant women with systemic lupus erythematosus (SLE) in the southern China.
Patients and methods: Between June 2014 and February 2020, we retrospectively analyzed the data of a total of 123 singleton pregnant women with SLE (mean age: 27.1±4.1 years; range, 19 to 39 years) who were referred to our rheumatology clinic. Demographic, clinical, and laboratory data of the patients were recorded. Adverse pregnancy outcomes (APOs) were assessed.
Results: Multivariate logistic regression analysis revealed that preeclampsia was associated with the increased odds of APOs (odds ratios [OR]=9.538, 95% confidence interval [CI]: 2.055-44.271, p=0.004), premature birth (OR=14.289, 95% CI: 3.596-56.777, p<0.001) and low birth weight (OR=8.275, 95% CI: 2.117-32.345, p=0.002). Anti-double-stranded deoxyribonucleic acid (anti-dsDNA) antibody positivity was the predictor of APOs (OR=2.165, 95% CI: 1.034-4.532, p=0.040), premature birth (OR=2.849, 95% CI: 1.220-6.657, p=0.016) and pregnancy loss (OR=3.004, 95% CI: 1.086-8.305, p=0.034). The use of hydroxychloroquine and prednisone was associated with the decreased odds of APOs (OR=0.412, 95% CI: 0.198-0.860, p=0.018) and pregnancy loss (OR=0.304, 95% CI: 0.111-0.831, p=0.020).
Conclusion: Our study results indicate that preeclampsia, anti-dsDNA antibody positivity, and the use of hydroxychloroquine and prednisone are independent predictors of pregnancy outcomes.
Keywords: Adverse pregnancy outcomes; preeclampsia; systemic lupus erythematosus..
Copyright © 2022, Turkish League Against Rheumatism.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Similar articles
-
Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.Clin Rheumatol. 2019 Dec;38(12):3501-3509. doi: 10.1007/s10067-019-04696-x. Epub 2019 Aug 3. Clin Rheumatol. 2019. PMID: 31377919
-
Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.Lupus. 2019 Oct;28(12):1417-1426. doi: 10.1177/0961203319877247. Epub 2019 Sep 24. Lupus. 2019. PMID: 31551036
-
Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.PLoS One. 2017 Apr 25;12(4):e0176457. doi: 10.1371/journal.pone.0176457. eCollection 2017. PLoS One. 2017. PMID: 28441446 Free PMC article.
-
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.Lupus. 2021 Jun;30(7):1163-1174. doi: 10.1177/09612033211007199. Epub 2021 Apr 15. Lupus. 2021. PMID: 33853420
-
Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.Arch Gynecol Obstet. 2021 Nov;304(5):1153-1160. doi: 10.1007/s00404-021-06178-5. Epub 2021 Aug 14. Arch Gynecol Obstet. 2021. PMID: 34390384 Review.
References
-
- Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: A systematic review of epidemiological studies. Rheumatology (Oxford) 2017;56:1945–1961. - PubMed
-
- Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol. 2013;149:211–218. - PubMed
-
- Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–485. - PMC - PubMed
LinkOut - more resources
Full Text Sources